<qa>  What is the name of the group with no placeboblank control?In this prospective study, there is only one group with no placeboblank control. All qualified IBS-D patients could be admitted to hospital for at least one time of combing therapy taking rifaximin for 3 days and then receiving fecal microbiota transplantation and follow-up until 6 months after the first treatment. 